Related Experiment Video
Updated: Jan 11, 2026
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Text messaging interventions are associated with reductions in HbA1c among patients with diabetes: a systematic
Neda Pirouzmand1, Grace S Ko2, Lucas C Godoy1,3,4,5
1University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.
Introduction:
Achieving optimal glycemic control remains challenging for many patients with diabetes. Text message-based interventions offer a scalable approach to enhance management. This systematic review and meta-analysis evaluated the impact of texting interventions on glycemic control in adults with diabetes.
Research Design And Methods:
We searched EMBASE, PubMed, and Cochrane CENTRAL for randomized controlled trials comparing texting interventions to standard care in high-income countries. The primary outcome was the between-group difference in hemoglobin A1c (HbA1c) change from baseline. Risk of bias and overall quality of evidence were assessed using the Cochrane and Grading of Recommendations Assessment, Development, and Evaluation tools respectively. Results were pooled using an inverse variance random-effects model. Heterogeneity was evaluated using the I2 statistic.
Results:
Over 3 months of follow-up (14 trials, n=1,460 intervention, n=1,487 control), texting interventions were associated with a 0.29-unit greater reduction in percent HbA1c over control (95% CI 0.14 to 0.45, p=0.0001, I2=57%). At 6 months (20 trials, n=2,332 intervention, n=2,371 control), texting was associated with 0.19-unit greater HbA1c reduction (95% CI 0.07 to 0.30, p=0.001 I2=45%). At 12 months (seven trials, n=2,038), there was a non-significant benefit associated with texting. Among studies with a mean baseline HbA1c ≥8.6%, texting was associated with 0.48- and 0.36-unit greater HbA1c reductions at 3 (p=0.004) and 6 (p=0.004) months, respectively. Subgroups were not significantly different.
Conclusion:
Text messaging interventions are associated with modest improvements in glycemic control over 3-6 months, particularly in patients with poorer baseline HbA1c. These effects may be meaningful at scale and support texting as a potential adjunct to routine diabetes care. Benefits appear to diminish by 12 months, underscoring the need for high-quality trials focused on long-term impact and intervention optimization.
Prospero Registration Number:
CRD42023416462.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
01:23Dipeptidyl Peptidase 4 Inhibitors